Intellia Therapeutics (NTLA) FCF Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | 11,733.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,733.00 |
| Dec 31, 2025 | 38,978.00 |
| Sep 30, 2025 | 6,591.00 |
| Jun 30, 2025 | -8,025.00 |
| Mar 31, 2025 | -15,392.00 |
| Dec 31, 2024 | -18,150.00 |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 6,738.00 |
| Mar 31, 2024 | 40,097.00 |
| Dec 31, 2023 | 544,645.00 |
| Sep 30, 2023 | -65,234.00 |
| Jun 30, 2023 | -105,166.00 |
| Mar 31, 2023 | -10,987.00 |
| Dec 31, 2022 | -40,533.00 |
| Sep 30, 2022 | -35,256.00 |
| Jun 30, 2022 | -36,580.00 |
| Mar 31, 2022 | -53,238.00 |
| Dec 31, 2021 | -38,602.00 |
| Sep 30, 2021 | -2.30 Mn |
| Jun 30, 2021 | -58,942.00 |
| Mar 31, 2021 | -56,396.00 |
| Dec 31, 2020 | -13,186.00 |
| Sep 30, 2020 | 2,665.00 |
| Jun 30, 2020 | 70,601.00 |
| Mar 31, 2020 | -59,832.00 |
| Dec 31, 2019 | -2,366.00 |
| Sep 30, 2019 | -10,260.00 |
| Jun 30, 2019 | -182,935.00 |
| Mar 31, 2019 | 37,192.00 |
| Dec 31, 2018 | 40,523.00 |
| Sep 30, 2018 | -7,659.00 |
| Jun 30, 2018 | -40,256.00 |
| Mar 31, 2018 | -59,752.00 |